S2-5 Predisposition to severe cutaneous ADRS in Europe(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本アレルギー学会の論文
- 2007-09-30
著者
-
Roujeau Jean-claude
Universite Paris Xii
-
Lonjou Christine
Universite Paul Sabatier, Hopital Purpan
-
Allanore Laurence
Universite Paris XII, Hopital Henri Mondor
-
Mokenhaupt Maja
Universitat Klinik, Freiburg, Germany
-
Sekula Peggy
Universitat Klinik, Freiburg, Germany
-
Hovnania Alain
Universite Paul Sabatier, Hopital Purpan
-
the RegiSCAR
Universite Paul Sabatier, Hopital Purpan
-
The Regiscar
Universite Paul Sabatier Hopital Purpan
-
Hovnania Alain
Universite Paul Sabatier Hopital Purpan
-
Mokenhaupt Maja
Universitat Klinik Freiburg Germany
-
Allanore Laurence
Universite Paris Xii Hopital Henri Mondor
-
Lonjou Christine
Universite Paul Sabatier Hopital Purpan
-
Sekula Peggy
Universitat Klinik Freiburg Germany
関連論文
- Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Are Severity Variants of the Same Disease which Differs from Erythema Multiforme
- S2-5 Predisposition to severe cutaneous ADRS in Europe(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)
- Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Are Severity Variants of the Same Disease, Different from Erythema Multiforme
- IL1 Immune mechanisms of drug eruption